Literature DB >> 8463918

Neonatal sepsis caused by a new group B streptococcal serotype.

M A Rench1, C J Baker.   

Abstract

Two infants with typical clinical presentations for invasive neonatal group B streptococcal disease caused by a new serotype, type V, are described. Organisms of this capsular type should be sought among isolates from sick neonates to evaluate their prevalence and associated patterns of disease.

Entities:  

Mesh：

Year:  1993        PMID： 8463918     DOI： 10.1016/s0022-3476(05)83554-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  12 in total

1.  High expression of a C protein beta antigen gene among invasive strains from certain clonally related groups of type Ia and Ib group B streptococci.

Authors:  Noriyuki Nagano; Yukiko Nagano; Fumiaki Taguchi
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Transcriptional and proteomic profiles of group B Streptococcus type V reveal potential adherence proteins associated with high-level invasion.

Authors:  Atul K Johri; Immaculada Margarit; Mark Broenstrup; Cecilia Brettoni; Lei Hua; Steven P Gygi; John L Telford; Guido Grandi; Lawrence C Paoletti
Journal:  Infect Immun       Date:  2007-01-08       Impact factor: 3.441

3.  Clonal relationship between U.S. and French serotype V group B streptococcus isolates.

Authors:  I Le Thomas-Bories; F Fitoussi; P Mariani-Kurkdjian; J Raymond; N Brahimi; P Bidet; V Lefranc; E Bingen
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

4.  Seroprevalence of antibodies to group B streptococcal polysaccharides in Gambian mothers and their newborns.

Authors:  R O Suara; R A Adegbola; E K Mulholland; B M Greenwood; C J Baker
Journal:  J Natl Med Assoc       Date:  1998-02       Impact factor: 1.798

5.  A serotype VIII strain among colonizing group B streptococcal isolates in Boston, Massachusetts.

Authors:  L J Paoletti; J Bradford; L C Paoletti
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

6.  Invasion of brain microvascular endothelial cells by group B streptococci.

Authors:  V Nizet; K S Kim; M Stins; M Jonas; E Y Chi; D Nguyen; C E Rubens
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

7.  Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.

Authors:  L C Paoletti; M R Wessels; A K Rodewald; A A Shroff; H J Jennings; D L Kasper
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Sensitivity and specificity of rapid diagnostic tests for detection of group B streptococcal antigen in bacteremic neonates.

Authors:  D N Greenberg; D P Ascher; B A Yoder; D M Hensley; H S Heiman; J F Keith
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

9.  Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching.

Authors:  Hilde-Kari Guttormsen; Lawrence C Paoletti; Keith G Mansfield; Wojcieck Jachymek; Harold J Jennings; Dennis L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-31       Impact factor: 11.205

10.  Selection, recombination, and virulence gene diversity among group B streptococcal genotypes.

Authors:  A Cody Springman; David W Lacher; Guangxi Wu; Nicole Milton; Thomas S Whittam; H Dele Davies; Shannon D Manning
Journal:  J Bacteriol       Date:  2009-07-06       Impact factor: 3.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.